About the Company
We do not have any company description for ELUTIA INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on ELUTIA INC.
Elutia Inc (ELUT) Q2 2025 Earnings Call Highlights: Strong EluPro Growth Amid Financial Challenges
Elutia Inc (ELUT) reports robust EluPro sales growth and strategic partnerships, but faces ongoing financial hurdles and ...
Elutia Inc. (NASDAQ:ELUT) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 14, 2025 Elutia Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.17. Operator: Good afternoon, ladies and gentlemen.
Elutia Inc. Reports Strong Growth and Strategic Advances
Aziyo Biologics, Inc. Class A ( (ELUT) ) has released its Q2 earnings. Here is a breakdown of the information Aziyo Biologics, Inc. Class A presented to its investors.Elevate Your Investing Strategy: ...
Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption
Strong Clinical Demand: EluPro customers are delivering meaningfully higher value than our legacy BioEnvelope platform, CanGaroo. In the second quarter, average sales per EluPro customer were 130% ...
Elutia Inc (ELUT) Q1 2025: Everything You Need To Know Ahead Of Earnings
Elutia Inc (NASDAQ:ELUT) is set to release its Q1 2025 earnings on May 8, 2025. The consensus estimate for Q1 2025 revenue is $6.65 million, and the earnings are expected to come in at -$0.21 per ...
Elutia Inc. to Release Fourth Quarter and Full Year 2024 ... - Nasdaq
Elutia Inc. has not provided any forward-looking guidance or commentary on the expected performance of its fourth quarter and full year 2024 results, which could lead to investor uncertainty.
Elutia Inc. Reports 18% Increase in BioEnvelope Sales Driven ... - Nasdaq
Elutia Inc. reported an 18% increase in BioEnvelope sales and a significant 65% rise in same-center sales attributed to the pilot launch of EluPro, its new antibiotic-eluting biomatrix product ...
Elutia Inc. sees $1.05 million stock purchase by HighCape entities
Elutia Inc., another company, reported a fourth-quarter revenue of $5.47 million, missing the expected $6.3 million and resulting in a stock drop.
Elutia Inc. sees $1.05 million stock purchase by HighCape entities
Elutia Inc., another company, reported a fourth-quarter revenue of $5.47 million, missing the expected $6.3 million and resulting in a stock drop. Despite this, Elutia highlighted positive ...
Similar Companies
Loading the latest forecasts...